TNFR-Fc fusion protein FDA Link

reduces tumor necrosis factor activity, as well as cytokine, chemokine, and stress hormone release; used to treat SPONDYLITIS, ANKYLOSING;

Also Known As:

etanercept; Enbrel; Immunex brand of etanercept; TNF receptor type II-IgG fusion protein; TNR 001; TNR-001; TNT receptor fusion protein; TNTR-Fc; Wyeth brand of etanercept; recombinant human dimeric TNF receptor type II-IgG fusion protein; soluble TNF receptor type I; soluble tumor necrosis factor receptor

Pharmalogical Action Categories:

Anti-Inflammatory Agents, Non-Steroidal
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Antirheumatic Agents

-

Amino Acids, Peptides, and Proteins

-

Proteins: 58433

-

Membrane Proteins: 4125

-

Cell Surface Receptors: 552

-

Immunologic Receptors: 6

-

Cytokine Receptors: 533

-

Tumor Necrosis Factor Receptors: 1814

*

TNFR-Fc fusion protein: 1738

-

Blood Proteins: 3862

-

Serum Globulins: 74

-

Immunoglobulins: 20136

-

Antibodies: 77322

-

Immunoglobulin Isotypes: 348

-

Immunoglobulin G: 31640

*

TNFR-Fc fusion protein: 1738

-

Immunoproteins: 30

-

Immunoglobulins: 20136

-

Antibodies: 77322

-

Immunoglobulin Isotypes: 348

-

Immunoglobulin G: 31640

*

TNFR-Fc fusion protein: 1738

-

Globulins: 305

-

Serum Globulins: 74

-

Immunoglobulins: 20136

-

Antibodies: 77322

-

Immunoglobulin Isotypes: 348

-

Immunoglobulin G: 31640

*

TNFR-Fc fusion protein: 1738

Ryozo Yano Selected Research

Articles by Research Topic

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure